ROMEOVILLE, Ill., June 02, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it entered into amendments on May 27, 2025 to its existing loan agreements, providing increased borrowing capacity to support the execution of strategic objectives.

NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced that it has closed two fixed rate mortgage financings totaling $94.3 million, secured by six senior housing communities managed by Five Star Senior Living, the operating division of AlerisLife Inc. The financings consist of a $64.0 million five-year mortgage loan and a $30.3 million ten-year Fannie Mae mortgage loan. Proceeds from these loans, together with cash on hand, will be used to repay the remainin.

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of the Thermo Scientific™ Orbitrap™ Astral™ Zoom mass spectrometer (MS) and the Thermo Scientific™ Orbitrap™ Excedion™ Pro mass spectrometer (MS) to help push the boundaries of scientific discovery. Delivering unrivaled analytical performance and speed, the instruments are designed to uncover complex biological processes that could lead to advancements in p.

INDIANAPOLIS , June 2, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new Phase 1 data showing that its folate receptor alpha (FRα) antibody-drug conjugate (ADC) (LY4170156) demonstrated an encouraging safety profile and anti-tumor activity across dose and FRα expression levels in women with heavily pre-treated platinum-resistant ovarian cancer, including patients previously treated with mirvetuximab soravtansine. A preliminary overall objective response rate (ORR) of 55% was observed at the potential recommended Phase 2 dose of 4 mg/kg.

SAN DIEGO , June 2, 2025 /PRNewswire/ -- PriceSmart, Inc. ("PriceSmart" or the "Company") (NASDAQ: PSMT) plans to release financial results for the third quarter of fiscal year 2025 on Thursday, July 10, 2025, after the market closes. PriceSmart management will host a conference call at 12:00 p.m.

Highlights strong momentum in driving profitable growth and delivering stockholder value Urges stockholders to vote “ FOR ” Oportun's two highly qualified nominees – Raul Vazquez and Carlos Minetti – on the GREEN proxy card Launches VoteForOportun.com , providing additional information for stockholders SAN CARLOS, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Oportun (Nasdaq: OPRT), a mission-driven financial services company, today issued a letter to stockholders detailing the progress Oportun's experienced management team and Board of Directors have made in driving financial and operational performance.

BOCA RATON, Fla. , June 2, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp.

NEW YORK , June 2, 2025 /PRNewswire/ -- WhiteFiber Inc., the wholly-owned HPC subsidiary of Bit Digital, Inc. (Nasdaq: BTBT) ("Bit Digital" or the "Company"), announced today that it has completed the acquisition of a 96-acre, ~1 million square foot industrial property in Madison, North Carolina. The Company will retrofit the facility into a flagship AI data center campus ("Facility").

MR-142 Achieved Primary Endpoint of ≥15-letter (≥3-line) Gain in Mesopic Low Contrast Distance Visual Acuity in Comparison to Placebo Results Showed Patient-Reported Functional Benefit in Treating Significant Chronic Night Driving Impairment in Keratorefractive Patients With Reduced Mesopic Vision, a Condition With No Current FDA-Approved Therapies No Evidence of Tachyphylaxis Was Observed In This Study Over The 6-Week Period Study Was Conducted Under FDA Special Protocol Assessment And Fast-Track Designation PITTSBURGH , June 2, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced positive top-line results from LYNX-2, a pivotal Phase 3 trial evaluating MR-142 (phentolamine ophthalmic …

LANGHORNE, Pa. , June 2, 2025 /PRNewswire/ -- TEN Holdings, Inc. (NASDAQ: XHLD) ("TEN Holdings" or the "Company"), a provider of event planning, production, and broadcasting services through its subsidiary, Ten Events, Inc., a Pennsyvania corporation ("Ten Events"), today announced the launch of an Early Adopter Program for its software-as-a-service ("SaaS") product, Ten Events Pro ("Ten Pro").

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that Rebecca McLeod has been appointed to the newly created role of Chief Brand Officer and U.S. General Manager. In this role, she will be responsible for leading the anticipated U.S. commercial launch of apitegromab fo.

ATLANTA--(BUSINESS WIRE)--BlueLinx Holdings Inc. (NYSE: BXC), a leading U.S. wholesale distributor of building products, and Louisiana-Pacific Corporation (LP Building Solutions, NYSE: LPX), a leading manufacturer of engineered wood building products, are pleased to announce the expansion of their distribution partnership to Springfield, Missouri. The expanded collaboration will include LP's renowned Siding Solutions brands and prefinished solutions, namely LP® SmartSide® Trim & Siding and.

CHEVY CHASE, Md. , June 2, 2025 /PRNewswire/ -- FCP® has closed on a $13.25 million preferred equity investment through its Structured Investments platform to finance Mosaic Pooler , a 333-unit, Class A multifamily development on Old Quacco Road in the dynamic Savannah submarket of Pooler, GA.

Marriott bolsters industry's largest residential portfolio with several signed agreements in desirable destinations around the world. NEW YORK , June 2, 2025 /PRNewswire/ -- Today, Marriott International, Inc. (Nasdaq: MAR), the industry leader in branded residential development, announces signed agreements in: Detroit, Michigan ; Muskoka, Canada; Gulf of Papagayo, Guanacaste, Costa Rica; and Jeddah, Saudi Arabia ; bringing the Marriott Branded Residences total open and pipeline portfolio to around 300 projects.

News Summary Up to six-fold increase in performance robustness with StepWave™ XR Ion Guide versus Xevo TQ Absolute.1 Uses up to 50% less power and gas, and occupies up to 50% less bench space than other products in its class.2 Takes the industry-leading sensitivity of Xevo TQ Absolute to new heights, including for PFAS detection and pharma quantitation applications. BALTIMORE and MILFORD, Mass.

Spanish service provider transforms key processes to enhance business agility and service delivery with Oracle Communications and Optare Solutions AUSTIN, Texas and MADRID , June 2, 2025 /PRNewswire/ -- Lyntia Networks, a leading neutral operator in the wholesale telecom sector, is relying on Oracle solutions to help meet its ambitious growth in the highly competitive infrastructure and connectivity markets. The operator is leveraging the out-of-the-box capabilities of Oracle Communications cloud native solutions to transform its operational support systems (OSS), enabling faster service delivery through automated orchestration processes.

Harmonic's cOS Broadband Platform Enables World's First PTP-less Deployment to Fuel Vectra's Network Transformation and Enable Wholesale Fiber and DOCSIS Offerings SAN JOSE, Calif. , June 2, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced that Vectra, one of the largest internet providers in Poland, has selected Harmonic's industry-leading cOS™ virtualized broadband platform to accelerate its multigigabit broadband service expansion, enable selective migration to deep fiber infrastructure and power its new wholesale fiber and DOCSIS offerings.

Hotel owners and property developers remain confident in industry's resiliency despite a news cycle dominated by tariffs, inflation, interest rates and more PARSIPPANY, N.J. , June 2, 2025 /PRNewswire/ -- Wyndham Hotels & Resorts today unveiled its first-annual Hotel Owner Trends Report.

Study met primary endpoint of ≥15-letter (≥3-line) gain in mesopic low contrast distance visual acuity in comparison to placebo Phase 3 study showed patient-reported functional benefit in treating significant, chronic night driving impairment in keratorefractive patients with reduced mesopic vision, a condition with no current FDA-approved therapies Safety profile consistent with previous studies, with no new safety signals identified No evidence of tachyphylaxis was observed in this study over the 6-week period Study was conducted under FDA Special Protocol Assessment and Fast-Track Designation RESEARCH TRIANGLE PARK, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage …

ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program.